Ligand ID: T0R Drugbank ID: DB00539(Toremifene) Indication:For the treatment of metastatic breast cancer in postmenopausal women with estrogen receptor-positive or receptor-unknown tumors. Toremifene is currently under investigation as a preventative agent for prostate cancer in men with high-grade prostatic intraepithelial neoplasia and no evidence of prostate cancer. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 1q2w | 3C-LIKE PROTEASE (SARSr-CoV) | 4 / 7 | LEU B 268THR B 292MET B 264LEU B 271 | 1.23A | 19.09 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 1wnc | E2 GLYCOPROTEIN (SARSr-CoV) | 5 / 7 | ARG F1166VAL F1170LEU F1174GLU F1169LEU F1167 | 1.46A | 15.45 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 1ysy | REPLICASEPOLYPROTEIN 1AB(PP1AB) (ORF1AB) (SARSr-CoV) | 4 / 7 | VAL A 55LEU A 19GLU A 52LEU A 78 | 0.98A | 17.26 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 2a5a | 3C-LIKE PEPTIDASE (SARSr-CoV) | 4 / 7 | LEU A 268THR A 292MET A 264LEU A 271 | 1.21A | 19.22 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 2a5k | 3C-LIKE PEPTIDASE (SARSr-CoV) | 4 / 7 | LEU B 268THR B 292MET B 264LEU B 271 | 1.21A | 19.16 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 2ahm | REPLICASEPOLYPROTEIN 1AB,LIGHT CHAIN (SARSr-CoV) | 5 / 7 | VAL C 71LEU C 76ALA C 70LEU C 64LEU C 22 | 1.29A | 18.58 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 2ahm | REPLICASEPOLYPROTEIN 1AB,HEAVY CHAIN (SARSr-CoV) | 5 / 7 | VAL G 31GLU G 28ALA G 32LEU G 40LEU G 43 | 1.70A | 20.96 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 2ajf | ACE2 (Homosapiens) | 4 / 7 | LEU B 281THR B 276ASP B 367LEU B 156 | 0.95A | 13.79 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 2alv | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 4 / 7 | LEU A 268THR A 292MET A 264LEU A 271 | 1.23A | 19.22 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 2d2d | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 7 | LEU B 268THR B 292MET B 264LEU B 271 | 1.25A | 18.91 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 2fe8 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 4 / 7 | VAL C 206GLU C 204ALA C 205LEU C 174 | 0.93A | 23.31 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 2fe8 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 4 / 7 | LEU A 254TYR A 297THR A 275LEU A 212 | 1.19A | 17.67 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 2ghw | ANTI-SCFV ANTIBODY,80R (Homosapiens) | 4 / 7 | VAL D 236LEU D 153ALA D 216LEU D 210 | 0.93A | 21.79 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 2hsx | LEADER PROTEIN P65 HOMOLOG NSP1 (SARSr-CoV) | 5 / 7 | ARG A 108VAL A 110LEU A 112LEU A 7LEU A 42 | 1.22A | 18.91 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 2k87 | NSP3 OF REPLICASEPOLYPROTEIN 1A (SARSr) | 4 / 7 | LEU A 25THR A 93THR A 94LEU A 108 | 1.06A | 20.23 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 2k87 | NSP3 OF REPLICASEPOLYPROTEIN 1A (SARSr) | 4 / 7 | LEU A 105THR A 97THR A 96LEU A 25 | 1.08A | 20.23 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 2qcy | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 7 | LEU A 268THR A 292MET A 264LEU A 271 | 1.18A | 19.22 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 2qiq | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 4 / 7 | LEU A 268THR A 292MET A 264LEU A 271 | 1.23A | 19.73 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 2w2g | NSP3 (SARSr-CoV) | 5 / 7 | VAL B 457LEU B 412ALA B 415LEU B 475LEU B 471 | 1.70A | 22.13 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 2wct | NSP3 (SARSr-CoV) | 4 / 7 | LEU A 596THR A 612ASP A 552LEU A 546 | 1.04A | 18.99 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 3aw0 | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 7 | LEU A 268THR A 292MET A 264LEU A 271 | 1.24A | 19.22 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 3bgf | F26G19 FAB (Musmusculus) | 5 / 7 | TYR C 94THR B 58THR B 57ASP B 56LEU B 100 | 1.80A | 19.52 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 3d0g | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 7 | VAL A 447LEU A 584ALA A 443LEU A 236LEU A 595 | 1.67A | 19.46 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 3d0h | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 4 / 7 | LEU B 281THR B 276ASP B 367LEU B 156 | 1.08A | 13.79 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 3d62 | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 7 | LEU A 268THR A 292MET A 264LEU A 271 | 1.23A | 19.80 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 3e9s | NSP3 (SARSr-CoV) | 4 / 7 | VAL A 206GLU A 204ALA A 205LEU A 174 | 1.00A | 23.12 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 3ea7 | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 7 | LEU B 205GLU B 270ALA B 266LEU B 272 | 1.05A | 21.20 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 3ea8 | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 7 | LEU A 268THR A 292MET A 264LEU A 271 | 1.22A | 17.48 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 3eaj | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 7 | LEU A 268THR A 292MET A 264LEU A 271 | 1.23A | 17.48 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 3eaj | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 7 | VAL A 296ALA A 291LEU A 253LEU A 250 | 1.02A | 21.20 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 3ebn | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 4 / 7 | LEU D 205GLU B 270ALA B 266LEU B 272 | 1.06A | 15.50 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 3f9e | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 7 | VAL A 212LEU A 220ALA A 211LEU A 253 | 1.08A | 21.37 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 3f9f | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 7 | LEU B 268THR B 292MET B 264LEU B 271 | 1.25A | 19.09 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 3f9g | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 7 | VAL B 212LEU B 220ALA B 211LEU B 253 | 1.06A | 20.76 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 3f9g | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 7 | LEU A 268THR A 292MET A 264LEU A 271 | 1.24A | 19.60 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 3f9h | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 7 | VAL A 212LEU A 220ALA A 211LEU A 253 | 1.08A | 20.87 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 3iwm | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 7 | VAL B 212LEU B 220ALA B 211LEU D 253 | 1.07A | 20.92 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 3m3s | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 7 | LEU A 268THR A 292MET A 264LEU A 271 | 1.23A | 19.22 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 3m3v | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 7 | LEU B 268THR B 292MET B 264LEU B 271 | 1.26A | 17.36 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 3scj | ACE2 (Homosapiens) | 4 / 7 | LEU B 281THR B 276ASP B 367LEU B 156 | 1.03A | 14.65 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 3sck | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 4 / 7 | LEU B 281THR B 276ASP B 367LEU B 156 | 0.97A | 14.65 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 4hi3 | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 7 | LEU B 268THR B 292MET B 264LEU B 271 | 1.25A | 20.89 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 4m0w | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 7 | VAL A 117LEU A 118ALA A 120LEU A 173LEU A 174 | 1.54A | 22.25 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 4m0w | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 4 / 7 | LEU A 254TYR A 297THR A 275LEU A 212 | 1.18A | 18.84 | GOL A 406 (-4.7A)NoneNoneNone | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 4ow0 | PAPAIN-LIKE PROTEASE (SARS-COVUrbani) | 4 / 7 | LEU B 254TYR B 297THR B 275LEU B 212 | 1.26A | 18.87 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 4ow0 | PAPAIN-LIKE PROTEASE (SARS-COVUrbani) | 5 / 7 | VAL A 117LEU A 118ALA A 120LEU A 173LEU A 174 | 1.51A | 23.24 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 5e6j | POLYUBIQUITIN-B (syntheticconstruct) | 5 / 7 | VAL F 26LEU F 15GLU F 24LEU F 43LEU F 50 | 1.36A | 11.82 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 5e6j | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 4 / 7 | LEU A 254TYR A 297THR A 275LEU A 212 | 1.25A | 18.96 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 5e6j | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 4 / 7 | VAL A 206GLU A 204ALA A 205LEU A 174 | 0.84A | 22.25 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 5tl7 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 7 | VAL B 117LEU B 118ALA B 120LEU B 173LEU B 174 | 1.53A | 23.31 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 5x58 | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 4 / 7 | VAL A 66LEU A 209LEU A 60LEU A 257 | 1.06A | 13.93 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 5x59 | S PROTEIN (MERS-CoV) | 5 / 7 | VAL C1082LEU C 835ALA C1083LEU C1078LEU C1040 | 1.52A | 13.60 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 5y3q | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 7 | VAL A 117LEU A 118ALA A 120LEU A 173LEU A 174 | 1.53A | 22.51 | NoneNone NA A 404 ( 3.8A)NoneNone | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 6acg | ACE2 (Homosapiens) | 4 / 7 | VAL D 404LEU D 554GLU D 402ALA D 403 | 1.10A | 18.88 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 6acg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 7 | LEU C 286TYR C 300ASP C 649LEU C 283 | 1.05A | 8.11 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 6cs1 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 4 / 7 | LEU B 286TYR B 300ASP B 649LEU B 283 | 1.18A | 11.35 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 6cs2 | ACE2 (Homosapiens) | 5 / 7 | VAL D 244LEU D 262ALA D 246LEU D 240LEU D 440 | 1.68A | 18.70 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 6jyt | HELICASE (SARSr-CoV) | 4 / 7 | LEU A 325THR A 307ASP A 374LEU A 297 | 1.13A | 12.40 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 6lzg | ACE2 (Homosapiens) | 4 / 7 | VAL A 404LEU A 554GLU A 402ALA A 403 | 1.10A | 18.95 | NoneNone ZN A 704 (-2.1A)None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 6m18 | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 4 / 7 | LEU A 541THR A 267ASP A 270MET A 542 | 1.16A | 13.96 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 6m1d | ACE2 (Homosapiens) | 5 / 7 | VAL D 447LEU D 584ALA D 443LEU D 236LEU D 595 | 1.51A | 17.44 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 6nb8 | S230 ANTIGEN-BINDING(FAB) FRAGMENT,HEAVY CHAIN (Homosapiens) | 4 / 7 | VAL H 123LEU H 20ALA H 92LEU H 86 | 1.07A | 22.26 | None | ||
![]() | 5JQ7_B_T0RB705_2 (ENVELOPEGLYCOPROTEIN 2) | 6nus | NSP12NSP8 (SARSr-CoV) | 4 / 7 | THR B 124THR B 123MET B 94LEU A 401 | 1.21A | 22.33 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 6nus | NSP12 (SARSr-CoV) | 4 / 7 | ARG A 631LEU A 308ALA A 634LEU A 663 | 1.07A | 15.87 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 6w41 | CR3022 FAB HEAVYCHAIN (Homosapiens) | 4 / 7 | VAL H 109ALA H 88LEU H 18LEU H 82 | 1.59A | 18.87 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 6w41 | CR3022 FAB LIGHTCHAIN (Homosapiens) | 4 / 7 | VAL L 196LEU L 136GLU L 195LEU L 201 | 1.30A | 20.32 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 6w41 | CR3022 FAB LIGHTCHAIN (Homosapiens) | 4 / 7 | VAL L 196LEU L 201LEU L 136LEU L 175 | 1.47A | 20.32 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 6w41 | CR3022 FAB LIGHTCHAIN (Homosapiens) | 4 / 7 | VAL L 196LEU L 201ALA L 144LEU L 135 | 1.21A | 20.32 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 6w41 | CR3022 FAB LIGHTCHAIN (Homosapiens) | 4 / 7 | VAL L 146LEU L 175GLU L 195LEU L 201 | 1.80A | 20.32 | None | ||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 6yla | LIGHT CHAIN (Homosapiens) | 4 / 7 | VAL C 202LEU C 207ALA C 150LEU C 141 | 1.25A | None | |||
![]() | 5JQ7_B_T0RB705_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | 6yla | LIGHT CHAIN (Homosapiens) | 4 / 7 | VAL L 202LEU L 207ALA L 150LEU L 141 | 1.26A | None |